CPT code 78811 represents a targeted positron emission tomography (PET) scan performed on a small, defined area of the body. As a focused nuclear imaging study, this procedure provides three-dimensional functional images useful for detecting and characterizing tumor cells and localized metabolic activity. Nationally, PET imaging remains a critical tool in oncology diagnosis, staging, and treatment planning, and targeted PET studies like 78811 allow clinicians to concentrate resources on specific clinical questions.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of how this service is categorized, typical sites of service, and which payers commonly cover targeted PET procedures. The publication summarizes common modifiers associated with imaging claims and outlines areas where clinical context drives utilization.

This briefing delivers practical reference material: a concise clinical description of CPT code 78811, payer coverage context, and the types of benchmarks and policy topics readers can expect in the full publication, including reimbursement benchmarking, claim coding considerations, and clinical appropriateness factors. Data not available in the input is noted where relevant.